NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for F...(-------- -------- Net loss ...),Health

Date:11/5/2009

-------- -------- Net loss $8.5 $9.5 Less: Depreciation amortization, interest, and taxes (6.5) (6.5) Less: Adjusting items* (0.5) (0.5) ---- ---- Adjusted EBITDA loss $1.5 $2.5 ==== ==== * Adjusting items include stock-based compensation, deferred revenue recognized and other non-recurring expenses

SOURCE NxStage Medical, Inc.

'/>"/>

SOURCE NxStage Medical, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine technology :

1. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
2. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
3. NxStage(R) to Report Third Quarter 2009 Financial Results
4. NxStage(R) Reports Significant Interim FREEDOM Study Results
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. Spherix Reports Second Quarter Earnings
7. Tapestry Reports Second Quarter 2007 Results
8. Callisto Reports on Second-Quarter 2007 Milestones
9. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress